🇺🇸 FDA

Drug profile · INN

glycopyrrolate

GLYCOPYRROLATE

FDA: approved
US status
approved
Patents linked
6
News articles
0

Quick answer

glycopyrrolate (GLYCOPYRROLATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.

Key facts

INN glycopyrrolate
Brand GLYCOPYRROLATE
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING
Originator Regeneron Ireland Designated Activity Company (DAC)

Related patents

Search patents →

  1. US 10548875

    Glycopyrrolate salts

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10543192

    Glycopyrrolate salts

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10004717

    Glycopyrrolate salts

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9610278

    Glycopyrrolate salts

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9259414

    Glycopyrrolate salts

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9006462

    Glycopyrrolate salts

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is glycopyrrolate?

glycopyrrolate (GLYCOPYRROLATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.

What is the brand name for glycopyrrolate?

GLYCOPYRROLATE is a marketed brand name for glycopyrrolate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of glycopyrrolate?

glycopyrrolate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.